Seoul Pharma Co., Ltd (KOSDAQ:018680)

Seoul Pharma Revenue

Seoul Pharma had revenue of 12.07B KRW in the quarter ending March 31, 2026, a decrease of -6.38%. This brings the company's revenue in the last twelve months to 51.33B, down -3.22% year-over-year. In the year 2025, Seoul Pharma had annual revenue of 52.15B, down -2.67%.

• Revenue (ttm): 51.33B
• Revenue Growth: -3.22%
• P/S Ratio: 0.51
• Revenue / Employee: 298.41M
• Employees: 172
• Market Cap: 26.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.15B	-1.43B	-2.67%
Dec 31, 2024	53.58B	1.12B	2.14%
Dec 31, 2023	52.46B	2.40B	4.80%
Dec 31, 2022	50.06B	9.59B	23.71%
Dec 31, 2021	40.46B	-11.77B	-22.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error